search
Back to results

Expanded Quantitative Urinary Culture (EQUC) vs Standard Culture (SUC) Techniques in the Clinical Care

Primary Purpose

Urinary Tract Infections

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Expanded Urinary Culture
Standard Urine Culture (SUC)
Sponsored by
Loyola University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Urinary Tract Infections

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • A "yes" answer to the screening question "do you feel you have a UTI"?
  • Non-pregnant women ages 18 years or older
  • Agreement to respond to a text or email question 7-10 days after treatment plan for their UTI (note: the treatment plan may include "no treatment").

Exclusion Criteria:

  • Women currently on antibiotics
  • Patients who cannot communicate or read in English
  • Patients under the age of 18
  • Pregnant patients
  • Women with an indwelling catheter and intermittent self-catheterization
  • Men
  • Urine obtained via the "clean catch method" (i.e. voided urine)
  • Women who refuse to be catheterized
  • Women who cannot or will not agree to respond to an email or text message 7-10 days after treatment plan is initiated.

Sites / Locations

  • Loyola University Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Expanded Urinary Culture (EQUC)

Standard Urine Culture (SUC)

Arm Description

Participants in this arm will receive the expanded urine culture

Participants in this arm will receive the standard urine culture

Outcomes

Primary Outcome Measures

Compare UTI symptom resolution rates in women with symptoms of UTI who are treated based on EQUC versus SUC results.
Using the FPMRS treatment algorithms (see appendix I & II Standard Urine Culture Treatment and Expanded Urine Culture Treatment Algorithms), attending physicians will treat participants based on their randomization to EQUC versus SUC. Following a 3-5 day standard course of treatment (which may include no antibiotics if the culture is negative), participants will be queried 7-10 days "do you continue to have UTI symptoms". Women who report "no" will be categorized as successful treatment, women who respond "yes" will be categorized as treatment failures.

Secondary Outcome Measures

Revise the EQUC treatment algorithm.
The EQUC treatment algorithm was based on known uropathogens that we had previously identified as most likely to be symptomatic. During the course of this work we may identify other pathogens that are present and causing symptoms. These organisms will be identified and added to the treatment algorithm. This interim analysis is planned and was part of the statistical calculations to determine sample size.
Identify the symptom profile associated with specific organisms.
Using the UTISA questionnaire, we will perform a symptoms association study with specific bacteria.

Full Information

First Posted
June 14, 2017
Last Updated
June 11, 2020
Sponsor
Loyola University
search

1. Study Identification

Unique Protocol Identification Number
NCT03190421
Brief Title
Expanded Quantitative Urinary Culture (EQUC) vs Standard Culture (SUC) Techniques in the Clinical Care
Official Title
The Use of Expanded Quantitative Urinary Culture (EQUC) Versus Standard Culture (SUC) Techniques in the Clinical Care of Women With Symptoms of Urinary Tract Infections.
Study Type
Interventional

2. Study Status

Record Verification Date
June 2020
Overall Recruitment Status
Completed
Study Start Date
June 15, 2017 (Actual)
Primary Completion Date
March 30, 2020 (Actual)
Study Completion Date
April 30, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Loyola University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This purpose of this study is to see if expanded urine culture techniques used in the laboratory improve the clinical care of women over standard urine culture techniques.
Detailed Description
The investigators request permission to recruit 225 women who respond "yes" to the question "do you feel you have a urinary tract infection". All participants will provide baseline urine specimens obtained by transurethral catheter (to avoid vulvo-vaginal contamination) and will complete a UTISA questionnaire to assess their current urinary tract symptoms. Participants will be randomized to the SUC treatment algorithm or the EQUC treatment algorithm. Treating physicians will receive either the SUC results or the EQUC results from the clinical laboratory and the results will be part of their clinical record. Treating physicians will follow the Loyola FPMRS treatment algorithm. Women in the study will also give consent for us to contact them using email, text messaging or phone call within 7-10 days after "treatment plan" has been implemented. The treatment plan options will include no treatment if the culture results show no pathogenic bacteria. All participants will be queried 7-10 days after their treatment plan (by email or text) "do you feel you continue to have a urinary tract infection". Women who respond "yes' will be asked to return for a second urine specimen which is our standard protocol. The second urine specimen will be analyzed using EQUC culture techniques only. Again, a treatment plan will be developed by the attending physician and the patient participant will be queried 7-10 days after the plan is implemented.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Urinary Tract Infections

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Expanded Quantitative Urinary Culture (EQUC) versus Standard Culture (SUC) Techniques
Masking
None (Open Label)
Allocation
Randomized
Enrollment
225 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Expanded Urinary Culture (EQUC)
Arm Type
Experimental
Arm Description
Participants in this arm will receive the expanded urine culture
Arm Title
Standard Urine Culture (SUC)
Arm Type
Active Comparator
Arm Description
Participants in this arm will receive the standard urine culture
Intervention Type
Diagnostic Test
Intervention Name(s)
Expanded Urinary Culture
Intervention Description
involves the inoculation of 100X (0.1mL) more urine onto diverse types of media (BAP, chocolate agar, colistin and nalidixic acid (CNA) agar, CDC anaerobe 5% BAP) with incubation in more environments and temperatures (5% CO2 at 35°C for 48 h, aerobic conditions at 35°C and 30°C for 48 h, Campy gas mixture (5% O2, 10% CO2, 85% N) or anaerobic conditions at 35°C for 48 h). The level of detection for EQUC is 10 CFU/mL, represented by 1 colony of growth on any of the plates. EQUC is designed to isolate a broad array of Gram-negative and Gram-positive bacteria, including anaerobes and fastidious bacteria that grow slowly.
Intervention Type
Diagnostic Test
Intervention Name(s)
Standard Urine Culture (SUC)
Intervention Description
involves inoculation of 0.001 mL of urine onto 5% sheep blood agar plate (BAP) and MacConkey agar plate with the plates being incubated aerobically at 35°C for 24 h. Thus, the level of detection for standard culture is 103 CFU/mL, represented by 1 colony of growth on either plate. Standard culture is designed specifically to grow Gram-negative rods, especially UPEC.
Primary Outcome Measure Information:
Title
Compare UTI symptom resolution rates in women with symptoms of UTI who are treated based on EQUC versus SUC results.
Description
Using the FPMRS treatment algorithms (see appendix I & II Standard Urine Culture Treatment and Expanded Urine Culture Treatment Algorithms), attending physicians will treat participants based on their randomization to EQUC versus SUC. Following a 3-5 day standard course of treatment (which may include no antibiotics if the culture is negative), participants will be queried 7-10 days "do you continue to have UTI symptoms". Women who report "no" will be categorized as successful treatment, women who respond "yes" will be categorized as treatment failures.
Time Frame
4 weeks
Secondary Outcome Measure Information:
Title
Revise the EQUC treatment algorithm.
Description
The EQUC treatment algorithm was based on known uropathogens that we had previously identified as most likely to be symptomatic. During the course of this work we may identify other pathogens that are present and causing symptoms. These organisms will be identified and added to the treatment algorithm. This interim analysis is planned and was part of the statistical calculations to determine sample size.
Time Frame
6 months
Title
Identify the symptom profile associated with specific organisms.
Description
Using the UTISA questionnaire, we will perform a symptoms association study with specific bacteria.
Time Frame
1 year

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: A "yes" answer to the screening question "do you feel you have a UTI"? Non-pregnant women ages 18 years or older Agreement to respond to a text or email question 7-10 days after treatment plan for their UTI (note: the treatment plan may include "no treatment"). Exclusion Criteria: Women currently on antibiotics Patients who cannot communicate or read in English Patients under the age of 18 Pregnant patients Women with an indwelling catheter and intermittent self-catheterization Men Urine obtained via the "clean catch method" (i.e. voided urine) Women who refuse to be catheterized Women who cannot or will not agree to respond to an email or text message 7-10 days after treatment plan is initiated.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elizabeth Mueller, MD
Organizational Affiliation
Loyola University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Loyola University Medical Center
City
Maywood
State/Province
Illinois
ZIP/Postal Code
60153
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
13380946
Citation
KASS EH. Asymptomatic infections of the urinary tract. Trans Assoc Am Physicians. 1956;69:56-64. No abstract available.
Results Reference
result
PubMed Identifier
86778
Citation
Maskell R, Pead L, Allen J. The puzzle of "urethral syndrome": a possible answer? Lancet. 1979 May 19;1(8125):1058-9. doi: 10.1016/s0140-6736(79)92953-2.
Results Reference
result
PubMed Identifier
22457796
Citation
Yuan S, Cohen DB, Ravel J, Abdo Z, Forney LJ. Evaluation of methods for the extraction and purification of DNA from the human microbiome. PLoS One. 2012;7(3):e33865. doi: 10.1371/journal.pone.0033865. Epub 2012 Mar 23.
Results Reference
result

Learn more about this trial

Expanded Quantitative Urinary Culture (EQUC) vs Standard Culture (SUC) Techniques in the Clinical Care

We'll reach out to this number within 24 hrs